EcoDrugPlus

Cyclin-Dependent Kinase 2

Ensembl ID : ENSGACG00000000539
Gene Symbol: CDK2
1 Cross references
203 Possible Orthologues:

Cyclin-Dependent Kinase 4

Ensembl ID : ENSGACG00000000585
Gene Symbol: CDK4
1 Cross references
239 Possible Orthologues:

Cyclin-Dependent Kinase 5

Ensembl ID : ENSGACG00000017975
Gene Symbol: CDK5
1 Cross references
169 Possible Orthologues:

Cyclin-Dependent Kinase 6

Ensembl ID : ENSGACG00000006323
Gene Symbol: CDK6
1 Cross references
200 Possible Orthologues:

Cyclin-Dependent Kinase 7

Ensembl ID : ENSGACG00000009848
Gene Symbol: CDK7
1 Cross references
219 Possible Orthologues:

Cyclin-Dependent Kinase 9 (Cdc2-Related Kinase)

Ensembl ID : ENSGACG00000018517
Gene Symbol: CDK9
1 Cross references
207 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSGACG00000018579
Gene Symbol: CYSLTR1
1 Cross references
177 Possible Orthologues:

Cytidine Deaminase B

Ensembl ID : ENSGACG00000007730
Gene Symbol: CDAB
1 Cross references
199 Possible Orthologues:

Cytochrome P450 Family 19 Subfamily A Member 1

Ensembl ID : ENSGACG00000005982
Gene Symbol: CYP19A1
1 Cross references
246 Possible Orthologues:

Cytochrome P450, Family 17, Subfamily A, Polypeptide 1

Ensembl ID : ENSGACG00000002550
Gene Symbol: CYP17A1
1 Cross references
211 Possible Orthologues:

Cytochrome P450, Family 19, Subfamily A, Polypeptide 1a

Ensembl ID : ENSGACG00000016742
Gene Symbol: CYP19A1A
1 Cross references
252 Possible Orthologues:

Cytochrome P450, Family 26, Subfamily A, Polypeptide 1

Ensembl ID : ENSGACG00000015370
Gene Symbol: CYP26A1
1 Cross references
194 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).